XML 27 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jan. 01, 2022   7,362,703    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 $ 215,784 $ (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 43,619   43,619  
Foreign currency translation adjustment (5,031)     (5,031)
Exercise of stock options (in shares)   61,645    
Exercise of stock options 1,411 $ 1,411    
Share-based compensation expense 4,773 $ 4,773    
Restricted shares vesting (in shares)   66,127    
Redemption of vested employee restricted shares for tax withholding (in shares)   (21,057)    
Redemption of vested employee restricted shares for tax withholding (2,145) $ (2,145)    
Shares repurchased (in shares)   (319,534)    
Shares repurchased (27,630) $ (2,296) (25,334)  
Accrued dividends on unvested shares (97)   (97)  
Cash dividends paid to shareholders (9,580)   (9,580)  
Ending balance (in shares) at Dec. 31, 2022   7,149,884    
Ending balance at Dec. 31, 2022 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 38,481   38,481  
Foreign currency translation adjustment 2,799     2,799
Exercise of stock options (in shares)   26,000    
Exercise of stock options 805 $ 805    
Share-based compensation expense 4,400 $ 4,400    
Restricted shares vesting (in shares)   83,158    
Redemption of vested employee restricted shares for tax withholding (in shares)   (28,619)    
Redemption of vested employee restricted shares for tax withholding (3,063) $ (3,063)    
Shares repurchased (in shares)   (296,158)    
Shares repurchased (31,417) $ (3,885) (27,532)  
Accrued excise tax on shares repurchased (247)   (247)  
Accrued dividends on unvested shares (4)   (4)  
Cash dividends paid to shareholders $ (10,807)   (10,807)  
Ending balance (in shares) at Dec. 30, 2023 6,934,265 6,934,265    
Ending balance at Dec. 30, 2023 $ 212,101 $ 0 224,283 (12,182)
Increase (Decrease) in Shareholders' Equity        
Net income 46,653   46,653  
Foreign currency translation adjustment (2,869)     (2,869)
Share-based compensation expense 5,291 $ 5,291    
Restricted shares vesting (in shares)   61,631    
Redemption of vested employee restricted shares for tax withholding (in shares)   (20,942)    
Redemption of vested employee restricted shares for tax withholding (3,209) $ (3,209)    
Shares repurchased (in shares)   (206,379)    
Shares repurchased (33,348) $ (419) (32,929)  
Accrued excise tax on shares repurchased (270)   (270)  
Dividends, Stock, Net (24)   (24)  
Cash dividends paid to shareholders $ (12,300)   (12,300)  
Ending balance (in shares) at Dec. 28, 2024 6,768,575 6,768,575    
Ending balance at Dec. 28, 2024 $ 212,073 $ 1,663 $ 225,461 $ (15,051)